High-dose cytosine arabinoside for the treatment of acute myeloid leukemia. Studies of the North American Marrow Transplant Group

Leukemia. 1992 Nov:6 Suppl 4:71-4.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Clinical Trial, Phase III
  • Review

MeSH terms

  • Cytarabine / adverse effects
  • Cytarabine / pharmacokinetics
  • Cytarabine / therapeutic use*
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*

Substances

  • Cytarabine